CLINICAL_TRIALS trial_result · 2015-05-15

Clinical Trial Update: Pediatric Chronic Kidney Disease Safety and Efficacy [Phase 3]

Phase 3 pediatric trial of a therapy for chronic kidney disease with secondary hyperparathyroidism was terminated; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Amgen | Conditions: Chronic Kidney Disease, Hyperparathyroidism | Phase 3 | Status: TERMINATED | Results posted: 2015-05-15